Tuesday, June 11, 2013

The display and use of drug information on this site is subject to express terms of use (click here). By continuing to view the drug information, you agree to abide such terms of use.

Rebif SubQ Medication Interactions


IMPORTANT NOTE: The following information is intended to supplement, not substitute for, the expertise and judgment of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that use of the drug is safe, appropriate or effective for you. Consult your healthcare professional before using this drug.

Generic Name: INTERFERON BETA 1A - SUBCUTANEOUS INJECTION
Pronounced: (in-ter-FEER-on bay-tah)

Rebif SubQ Interactions

Drug interactions may change how your medications work or increase your risk for serious side effects. This document does not contain all possible drug interactions. Keep a list of all the products you use (including prescription/nonprescription drugs and herbal products) and share it with your doctor and pharmacist. Do not start, stop, or change the dosage of any medicines without your doctor's approval.

Some products that may interact with this drug include:

  • other drugs that may suppress your immune system (e.g., azathioprine, cyclosporine, prednisone, hydroxyurea)
  • other drugs/herbals that may harm your liver (e.g., isoniazid, kava, methotrexate, nefazodone)
  • telbivudine
  • theophylline


CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.
Information last revised November 2010 Copyright(c) 2010 First DataBank, Inc.